To determine whether elevated plasma glypican levels could predict the development of organ failure, patients in the sepsis group were further subdivided into two groups: (a) patients who already had organ failure at the time of enrollment and plasma sampling and (b) patients who developed organ failure after enrollment and plasma sampling, and these groups were compared to patients with infection without organ failure. The gene discussed is GPC1; the disease is infection.